OKYO Pharma (OKYO) Current Assets (2021 - 2026)
OKYO Pharma (OKYO) posted quarterly Current Assets of $21.0 million for Q1 2026, up 470.57% year-over-year from $3.7 million in Q1 2025, and up 351.68% quarter-over-quarter from $4.6 million in Q3 2025.
OKYO Pharma (OKYO) Current Assets (2021 - 2026) Analysis & Trends
OKYO Pharma (OKYO) has reported Current Assets for 6 consecutive years, with $21.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets rose 470.57% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $21.0 million (up 470.57% YoY), while the FY2026 annual figure was $21.0 million, up 470.57% from the prior year.
- Current Assets advanced to $21.0 million in Q1 2026 per OKYO's latest filing, from $4.6 million in the prior quarter.
- Across five years, Current Assets topped out at $21.0 million in Q1 2026 and bottomed at $1.5 million in Q1 2024.
- Historically, Current Assets has averaged $5.7 million across 5 years, with a median of $4.0 million in 2022.
- Annual changes were most pronounced in 2024 — Current Assets plunged 70.41% — and 2026, when it jumped 470.57%.
- OKYO Pharma's Current Assets stood at $4.3 million in 2022, then tumbled by 44.78% to $2.4 million in 2023, then increased by 19.17% to $2.8 million in 2024, then soared by 64.24% to $4.6 million in 2025, then surged by 351.68% to $21.0 million in 2026.
- Business Quant data shows OKYO's Current Assets at $21.0 million in Q1 2026, $4.6 million in Q3 2025, and $3.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | OKYO Pharma | 1.47 Bn | 1.47 Bn | - | 20.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.97 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Mar 31, 2025 | 3.68 Mn |
| Sep 30, 2024 | 2.83 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Mar 31, 2023 | 5.20 Mn |
| Mar 31, 2022 | 4.30 Mn |
| Mar 31, 2021 | 6.99 Mn |